Halozyme Therapeutics Inc (HALO)
38.18
+1.67 (+4.57%)
USD |
NASDAQ |
Mar 29, 16:00
38.18
0.00 (0.00%)
After-Hours: 20:00
Halozyme Therapeutics Price: 38.18 for March 29, 2023
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 28, 2023 | 35.54 | 36.66 | 35.45 | 36.51 | 1.505M |
| Mar 27, 2023 | 34.87 | 36.24 | 34.69 | 35.70 | 2.578M |
| Mar 24, 2023 | 33.59 | 34.74 | 33.42 | 34.49 | 1.630M |
| Mar 23, 2023 | 32.86 | 33.85 | 32.86 | 33.68 | 2.350M |
| Mar 22, 2023 | 34.40 | 34.84 | 32.83 | 32.86 | 2.259M |
| Mar 21, 2023 | 35.07 | 35.48 | 34.14 | 34.59 | 2.550M |
| Mar 20, 2023 | 33.50 | 35.17 | 33.25 | 34.82 | 3.427M |
| Mar 17, 2023 | 35.83 | 36.32 | 32.93 | 33.08 | 6.674M |
| Mar 16, 2023 | 39.30 | 39.30 | 35.97 | 36.07 | 5.449M |
| Mar 15, 2023 | 41.14 | 41.20 | 39.57 | 40.05 | 2.480M |
| Mar 14, 2023 | 43.24 | 43.66 | 41.34 | 42.00 | 1.630M |
| Mar 13, 2023 | 41.46 | 43.47 | 41.46 | 42.91 | 1.374M |
| Mar 10, 2023 | 42.55 | 42.69 | 41.36 | 41.63 | 1.125M |
| Mar 09, 2023 | 42.54 | 43.36 | 42.46 | 42.74 | 1.187M |
| Mar 08, 2023 | 43.53 | 43.66 | 42.26 | 42.51 | 1.707M |
| Mar 07, 2023 | 45.62 | 45.92 | 43.32 | 43.40 | 2.075M |
| Mar 06, 2023 | 46.06 | 46.32 | 45.17 | 45.48 | 2.259M |
| Mar 03, 2023 | 46.20 | 46.60 | 45.57 | 46.37 | 887837.0 |
| Mar 02, 2023 | 47.27 | 47.46 | 46.00 | 46.03 | 1.336M |
| Mar 01, 2023 | 47.71 | 48.31 | 47.46 | 47.62 | 724430.0 |
| Feb 28, 2023 | 48.51 | 48.74 | 47.74 | 47.99 | 1.579M |
| Feb 27, 2023 | 49.80 | 49.80 | 48.53 | 48.55 | 662344.0 |
| Feb 24, 2023 | 50.00 | 51.04 | 49.40 | 49.54 | 940624.0 |
| Feb 23, 2023 | 50.00 | 51.45 | 49.40 | 50.35 | 1.313M |
| Feb 22, 2023 | 49.00 | 51.39 | 48.21 | 50.08 | 1.436M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
13.33
Minimum
Dec 24 2018
59.44
Maximum
Dec 02 2022
30.67
Average
28.53
Median
Price Benchmarks
| Tandem Diabetes Care Inc | 38.76 |
| BioCryst Pharmaceuticals Inc | 8.57 |
| bluebird bio Inc | 3.255 |
| Integra Lifesciences Holdings Corp | 55.50 |
| TELA Bio Inc | 11.26 |
Price Related Metrics
| PE Ratio | 26.33 |
| PS Ratio | 8.130 |
| Price to Book Value | 30.44 |
| Price to Free Cash Flow | 22.81 |
| Earnings Yield | 3.80% |
| Market Cap | 5.168B |
| Operating PE Ratio | 20.06 |
| Normalized PE Ratio | 26.11 |